{"transactions":[{"id":679346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-08-21T20:01:23.000Z","date":"2026-08-19","kind":"exercise","planned":false,"acquired":false,"shares":12282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12283,"derivative":{"exercise_price":381.92,"expiration_date":"2026-12-16","underlying":"Common Stock","underlying_shares":12282},"source":{"system":"sec-edgar","filing":"0001238303-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830326000002/edgardoc.xml","form_type":"4"}},{"id":679345,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2026-08-21T20:01:23.000Z","date":"2026-08-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":9019,"price":830.15,"value":7487122.85,"ownership":{"direct":true},"balance_after":36373,"source":{"system":"sec-edgar","filing":"0001238303-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830326000002/edgardoc.xml","form_type":"4"}},{"id":679344,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2026-08-21T20:01:23.000Z","date":"2026-08-19","kind":"exercise","planned":false,"acquired":true,"shares":12282,"price":381.92,"value":4690741.44,"ownership":{"direct":true},"balance_after":45392,"source":{"system":"sec-edgar","filing":"0001238303-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830326000002/edgardoc.xml","form_type":"4"}},{"id":976904,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T21:09:43.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":12210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12210,"derivative":{"exercise_price":726.71,"expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":12210},"source":{"system":"sec-edgar","filing":"0001238303-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000007/edgardoc.xml","form_type":"4"}},{"id":976903,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2025-12-09T21:09:43.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":712.94,"value":995264.24,"ownership":{"direct":true},"balance_after":29517,"source":{"system":"sec-edgar","filing":"0001238303-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000007/edgardoc.xml","form_type":"4"}},{"id":976902,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2025-12-09T21:09:43.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":2476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029."}],"balance_after":30913,"source":{"system":"sec-edgar","filing":"0001238303-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000007/edgardoc.xml","form_type":"4"}},{"id":990651,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-11-24T21:07:16.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":14450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":14450},"source":{"system":"sec-edgar","filing":"0001238303-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000005/edgardoc.xml","form_type":"4"}},{"id":990650,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2025-11-24T21:07:16.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12686,"price":736.77,"value":9346664.22,"ownership":{"direct":true},"balance_after":22839,"source":{"system":"sec-edgar","filing":"0001238303-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000005/edgardoc.xml","form_type":"4"}},{"id":990649,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2025-11-24T21:07:16.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":14450,"price":555.67,"value":8029431.5,"ownership":{"direct":true},"balance_after":35525,"source":{"system":"sec-edgar","filing":"0001238303-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123830325000005/edgardoc.xml","form_type":"4"}},{"id":1327432,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-12-18T21:01:51.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":702,"price":730.81,"value":513028.62,"ownership":{"direct":true},"balance_after":30075,"source":{"system":"sec-edgar","filing":"0001883850-24-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000062/edgardoc.xml","form_type":"4"}},{"id":1338105,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-10T21:02:49.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":8981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":8981,"derivative":{"exercise_price":771.64,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":8981},"source":{"system":"sec-edgar","filing":"0001968202-24-000135","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000135/edgardoc.xml","form_type":"4"}},{"id":1338104,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-12-10T21:02:49.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":492,"price":787,"value":387204.0,"ownership":{"direct":true},"balance_after":30777,"source":{"system":"sec-edgar","filing":"0001968202-24-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000135/edgardoc.xml","form_type":"4"}},{"id":1338103,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-12-10T21:02:49.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":2332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028."}],"balance_after":31269,"source":{"system":"sec-edgar","filing":"0001968202-24-000135","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000135/edgardoc.xml","form_type":"4"}},{"id":1455618,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-07-12T20:00:17.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":1866,"price":1088.95,"value":2031980.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024."}],"balance_after":37937,"source":{"system":"sec-edgar","filing":"0001968202-24-000107","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000107/edgardoc.xml","form_type":"4"}},{"id":1470032,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-25T20:39:50.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":false,"shares":14450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":14450,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":14450},"source":{"system":"sec-edgar","filing":"0001883850-24-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000036/edgardoc.xml","form_type":"4"}},{"id":1470031,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-06-25T20:39:50.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":11084,"price":1060.13,"value":11750480.92,"ownership":{"direct":true},"balance_after":39803,"source":{"system":"sec-edgar","filing":"0001883850-24-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000036/edgardoc.xml","form_type":"4"}},{"id":1470030,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-06-25T20:39:50.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":true,"shares":14450,"price":555.67,"value":8029431.5,"ownership":{"direct":true},"balance_after":50887,"source":{"system":"sec-edgar","filing":"0001883850-24-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000036/edgardoc.xml","form_type":"4"}},{"id":1482639,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-06-12T20:10:05.000Z","date":"2024-06-10","kind":"gift","planned":false,"acquired":false,"shares":1608,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2022 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001883850-24-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000032/edgardoc.xml","form_type":"4"}},{"id":1506196,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-05-22T20:02:37.000Z","date":"2024-05-21","kind":"sale","planned":true,"acquired":false,"shares":1865,"price":994.9,"value":1855488.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024."}],"balance_after":34678,"source":{"system":"sec-edgar","filing":"0001968202-24-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000096/edgardoc.xml","form_type":"4"}},{"id":1613537,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:48.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":990,"value":990000.0,"ownership":{"direct":true},"balance_after":36543,"source":{"system":"sec-edgar","filing":"0001968202-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000080/edgardoc.xml","form_type":"4"}},{"id":1620739,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-02-26T21:07:33.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":967.65,"value":967650.0,"ownership":{"direct":true},"balance_after":37543,"source":{"system":"sec-edgar","filing":"0001968202-24-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000073/edgardoc.xml","form_type":"4"}},{"id":1652284,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-02-09T21:12:25.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":950,"value":950000.0,"ownership":{"direct":true},"balance_after":38543,"source":{"system":"sec-edgar","filing":"0001968202-24-000058","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000058/edgardoc.xml","form_type":"4"}},{"id":1689487,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:19:41.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001883850-24-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000006/edgardoc.xml","form_type":"4"}},{"id":1689486,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-01-04T21:19:41.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24493,"price":912.3,"value":22344963.9,"ownership":{"direct":true},"balance_after":39543,"source":{"system":"sec-edgar","filing":"0001883850-24-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000006/edgardoc.xml","form_type":"4"}},{"id":1689485,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2024-01-04T21:19:41.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":34000,"price":399.66,"value":13588440.0,"ownership":{"direct":true},"balance_after":64036,"source":{"system":"sec-edgar","filing":"0001883850-24-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000006/edgardoc.xml","form_type":"4"}},{"id":1715276,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-12T21:01:54.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":7649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7649,"derivative":{"exercise_price":843.79,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":7649},"source":{"system":"sec-edgar","filing":"0001968202-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000052/edgardoc.xml","form_type":"4"}},{"id":1715275,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:54.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":669,"price":844.09,"value":564696.21,"ownership":{"direct":true},"balance_after":30036,"source":{"system":"sec-edgar","filing":"0001968202-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000052/edgardoc.xml","form_type":"4"}},{"id":1715274,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:54.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":2133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2025 and 50% on December 8, 2027."}],"balance_after":30705,"source":{"system":"sec-edgar","filing":"0001968202-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000052/edgardoc.xml","form_type":"4"}},{"id":1715273,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-12-12T21:01:54.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":852,"price":843.79,"value":718909.08,"ownership":{"direct":true},"balance_after":28572,"source":{"system":"sec-edgar","filing":"0001968202-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000052/edgardoc.xml","form_type":"4"}},{"id":1938437,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-27T20:39:22.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001883850-23-000061","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000061/edgardoc.xml","form_type":"4"}},{"id":1938436,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-03-27T20:39:22.000Z","date":"2023-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":6742,"price":801.59,"value":5404319.78,"ownership":{"direct":true},"balance_after":27471,"source":{"system":"sec-edgar","filing":"0001883850-23-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000061/edgardoc.xml","form_type":"4"}},{"id":1938435,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-03-27T20:39:22.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":270.43,"value":2704300.0,"ownership":{"direct":true},"balance_after":34213,"source":{"system":"sec-edgar","filing":"0001883850-23-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000061/edgardoc.xml","form_type":"4"}},{"id":1955422,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2023-03-14T20:08:13.000Z","date":"2023-03-10","kind":"gift","acquired":false,"shares":1006,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2021 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001968202-23-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000002/edgardoc.xml","form_type":"4"}},{"id":2080312,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T21:07:37.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":10159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10159,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":10159},"source":{"system":"sec-edgar","filing":"0001883850-22-000133","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000133/edgardoc.xml","form_type":"4"}},{"id":2080311,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-12-20T21:07:37.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":2752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026."}],"balance_after":23110,"source":{"system":"sec-edgar","filing":"0001883850-22-000133","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000133/edgardoc.xml","form_type":"4"}},{"id":2088771,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-12-13T21:12:58.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":492,"price":753.28,"value":370613.76,"ownership":{"direct":true},"balance_after":20358,"source":{"system":"sec-edgar","filing":"0001883850-22-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000122/edgardoc.xml","form_type":"4"}},{"id":2161683,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-12T20:30:29.000Z","date":"2022-09-09","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":270.43,"expiration_date":"2023-12-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001883850-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000067/edgardoc.xml","form_type":"4"}},{"id":2161682,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-09-12T20:30:29.000Z","date":"2022-09-09","kind":"tax_withholding","acquired":false,"shares":20730,"price":730.96,"value":15152800.8,"ownership":{"direct":true},"balance_after":20850,"source":{"system":"sec-edgar","filing":"0001883850-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000067/edgardoc.xml","form_type":"4"}},{"id":2161681,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-09-12T20:30:29.000Z","date":"2022-09-09","kind":"exercise","acquired":true,"shares":30000,"price":270.43,"value":8112900.0,"ownership":{"direct":true},"balance_after":41580,"source":{"system":"sec-edgar","filing":"0001883850-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000067/edgardoc.xml","form_type":"4"}},{"id":2299680,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-11T20:41:26.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":5114,"price":721.1,"value":3687705.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 5,114 shares of Company stock on April 7, 2022 at prices ranging from $721.10 to $721.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 7, 2022 at each separate price."}],"balance_after":16900,"source":{"system":"sec-edgar","filing":"0001708138-22-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000040/edgardoc.xml","form_type":"4"}},{"id":2309799,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":15,"price":701.82,"value":10527.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22014,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309798,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":124,"price":698.26,"value":86584.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22029,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309797,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":64,"price":697.35,"value":44630.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22153,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309796,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":254,"price":696.54,"value":176921.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 254 shares of Company stock on April 1, 2022 at prices ranging from $696.12 to $696.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":22217,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309795,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":305,"price":695.36,"value":212084.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 305 shares of Company stock on April 1, 2022 at prices ranging from $695.01 to $695.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":22471,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309794,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":259,"price":694.56,"value":179891.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 259 shares of Company stock on April 1, 2022 at prices ranging from $694.15 to $694.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":22776,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309793,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":567,"price":693.92,"value":393452.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 567 shares of Company stock on April 1, 2022 at prices ranging from $693.62 to $693.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":23035,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309792,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":195,"price":692.54,"value":135045.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 195 shares of Company stock on April 1, 2022 at prices ranging from $692.10 to $692.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":23602,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309791,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":641,"price":691.44,"value":443213.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 641 shares of Company stock on April 1, 2022 at prices ranging from $691.07 to $691.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":23797,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309790,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":250,"price":690.51,"value":172627.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 250 shares of Company stock on April 1, 2022 at prices ranging from $690.30 to $690.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":24438,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309789,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":218,"price":689.43,"value":150295.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 218 shares of Company stock on April 1, 2022 at prices ranging from $689.07 to $689.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":24688,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309788,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":799,"price":688.59,"value":550183.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 799 shares of Company stock on April 1, 2022 at prices ranging from $688.05 to $688.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":24906,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309787,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":497,"price":687.41,"value":341642.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 497 shares of Company stock on April 1, 2022 at prices ranging from $687.12 to $687.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":25705,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309786,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":557,"price":686.26,"value":382246.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 557 shares of Company stock on April 1, 2022 at prices ranging from $686.15 to $686.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":26202,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2309785,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2022-04-04T20:04:03.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":369,"price":685.71,"value":253026.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 369 shares of Company stock on April 1, 2022 at prices ranging from $685.49 to $685.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2022 at each separate price."}],"balance_after":26759,"source":{"system":"sec-edgar","filing":"0001708138-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000033/edgardoc.xml","form_type":"4"}},{"id":2474341,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-12-14T21:07:05.000Z","date":"2021-12-11","kind":"tax_withholding","acquired":false,"shares":697,"price":664.34,"value":463044.98,"ownership":{"direct":true},"balance_after":26051,"source":{"system":"sec-edgar","filing":"0001708138-21-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000103/edgardoc.xml","form_type":"4"}},{"id":2477914,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-10T22:30:57.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":14253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":14253,"derivative":{"exercise_price":644.54,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":14253},"source":{"system":"sec-edgar","filing":"0001883850-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000023/edgardoc.xml","form_type":"4"}},{"id":2477913,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-10T22:30:57.000Z","date":"2021-12-09","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001883850-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000023/edgardoc.xml","form_type":"4"}},{"id":2477912,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-12-10T22:30:57.000Z","date":"2021-12-09","kind":"tax_withholding","acquired":false,"shares":19772,"price":657.11,"value":12992378.92,"ownership":{"direct":true},"balance_after":26748,"source":{"system":"sec-edgar","filing":"0001883850-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000023/edgardoc.xml","form_type":"4"}},{"id":2477911,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-12-10T22:30:57.000Z","date":"2021-12-09","kind":"exercise","acquired":true,"shares":30000,"price":179.13,"value":5373900.0,"ownership":{"direct":true},"balance_after":46520,"source":{"system":"sec-edgar","filing":"0001883850-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000023/edgardoc.xml","form_type":"4"}},{"id":2477910,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-12-10T22:30:57.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":3338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025."}],"balance_after":16520,"source":{"system":"sec-edgar","filing":"0001883850-21-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385021000023/edgardoc.xml","form_type":"4"}},{"id":2592908,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2592907,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":1,"price":666.22,"value":666.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":13182,"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2592906,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":41,"price":665.4,"value":27281.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price."}],"balance_after":13183,"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2592905,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":3383,"price":661.8,"value":2238869.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":13224,"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2592904,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":6575,"price":664.85,"value":4371388.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":16607,"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2592903,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-08-24T20:06:03.000Z","date":"2021-08-20","kind":"exercise","acquired":true,"shares":10000,"price":179.13,"value":1791300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":23182,"source":{"system":"sec-edgar","filing":"0001237899-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000018/edgardoc.xml","form_type":"4"}},{"id":2640113,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-07T20:01:47.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":179.13,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001708138-21-000036","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000036/edgardoc.xml","form_type":"4"}},{"id":2640112,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-07-07T20:01:47.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":3398,"price":580,"value":1970840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":13182,"source":{"system":"sec-edgar","filing":"0001708138-21-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000036/edgardoc.xml","form_type":"4"}},{"id":2640111,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-07-07T20:01:47.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":6602,"price":582.2,"value":3843684.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":16580,"source":{"system":"sec-edgar","filing":"0001708138-21-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000036/edgardoc.xml","form_type":"4"}},{"id":2640110,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2021-07-07T20:01:47.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":10000,"price":179.13,"value":1791300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":23182,"source":{"system":"sec-edgar","filing":"0001708138-21-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000036/edgardoc.xml","form_type":"4"}},{"id":2949261,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-12-11T21:03:50.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":19950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":19950,"derivative":{"exercise_price":492,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":19950},"source":{"system":"sec-edgar","filing":"0001237899-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000050/edgardoc.xml","form_type":"4"}},{"id":2949260,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-12-11T21:03:50.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":1930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 9, 2022 and 50% on December 9, 2024."}],"balance_after":16368,"source":{"system":"sec-edgar","filing":"0001237899-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000050/edgardoc.xml","form_type":"4"}},{"id":3044137,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"With respect to 6,000 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.  With respect to 4,000 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044136,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"With respect to 6,000 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.  With respect to 4,000 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":4000,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044135,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":4672,"price":615.04,"value":2873466.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 4,672 shares of Company stock on August 31, 2020 at prices ranging from $615.00 to $615.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price."}],"balance_after":14438,"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044134,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"tax_withholding","acquired":false,"shares":2131,"price":614.87,"value":1310287.97,"ownership":{"direct":true},"balance_after":19110,"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044133,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":4000,"price":52.03,"value":208120.0,"ownership":{"direct":true},"balance_after":21241,"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044132,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"tax_withholding","acquired":false,"shares":3197,"price":614.87,"value":1965739.39,"ownership":{"direct":true},"balance_after":17241,"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3044131,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-08-31T20:37:49.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":6000,"price":52.03,"value":312180.0,"ownership":{"direct":true},"balance_after":20438,"source":{"system":"sec-edgar","filing":"0001237899-20-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000039/edgardoc.xml","form_type":"4"}},{"id":3147992,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-15T20:03:56.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":18311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":59.2,"expiration_date":"2021-09-01","underlying":"Common Stock","underlying_shares":18311},"source":{"system":"sec-edgar","filing":"0001237899-20-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000020/edgardoc.xml","form_type":"4"}},{"id":3147991,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-05-15T20:03:56.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":8380,"price":572,"value":4793360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":14438,"source":{"system":"sec-edgar","filing":"0001237899-20-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000020/edgardoc.xml","form_type":"4"}},{"id":3147990,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-05-15T20:03:56.000Z","date":"2020-05-14","kind":"tax_withholding","acquired":false,"shares":9931,"price":573.18,"value":5692250.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22818,"source":{"system":"sec-edgar","filing":"0001237899-20-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000020/edgardoc.xml","form_type":"4"}},{"id":3147989,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-05-15T20:03:56.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":18311,"price":59.2,"value":1084011.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":32749,"source":{"system":"sec-edgar","filing":"0001237899-20-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000020/edgardoc.xml","form_type":"4"}},{"id":3173405,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Form two of two"}],"balance_after":18311,"derivative":{"exercise_price":59.2,"expiration_date":"2021-09-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173404,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":6622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":23311,"derivative":{"exercise_price":59.2,"expiration_date":"2021-09-01","underlying":"Common Stock","underlying_shares":6622},"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173403,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":29933,"derivative":{"exercise_price":59.2,"expiration_date":"2021-09-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173402,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":577,"price":573.59,"value":330961.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 577 shares of Company stock on April 20, 2020 at prices ranging from $573.31 to $573.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":14438,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173401,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":61,"price":572.94,"value":34949.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":15015,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173400,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":112,"price":571.65,"value":64024.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":15076,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173399,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":125,"price":570.27,"value":71283.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 125 shares of Company stock on April 20, 2020 at prices ranging from $570.03 to $570.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":15188,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173398,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":234,"price":569.41,"value":133241.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 234 shares of Company stock on April 20, 2020 at prices ranging from $569.22 to $569.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":15313,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173397,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:27:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":669,"price":567.3,"value":379523.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 669 shares of Company stock on April 20, 2020 at prices ranging from $567.00 to $567.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":15547,"source":{"system":"sec-edgar","filing":"0001708138-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000043/edgardoc.xml","form_type":"4"}},{"id":3173365,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":1189,"price":566.44,"value":673497.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 1,189 shares of Company stock on April 20, 2020 at prices ranging from $566.00 to $566.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F13","text":"Form one of two"}],"balance_after":16216,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173364,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":1468,"price":565.6,"value":830300.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 1,468 shares of Company stock on April 20, 2020 at prices ranging from $565.03 to $565.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":17405,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173363,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":377,"price":564.74,"value":212906.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 377 shares of Company stock on April 20, 2020 at prices ranging from $564.03 to $564.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":18873,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173362,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":416,"price":563.58,"value":234449.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 416 shares of Company stock on April 20, 2020 at prices ranging from $563.35 to $563.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price."}],"balance_after":19250,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173361,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":21,"price":562.71,"value":11816.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19666,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173360,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":51,"price":561.57,"value":28640.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19687,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}},{"id":3173359,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":14140,"kind":"person","name":"LAROSA JOSEPH J","position":1,"cik":"0001238303","reported_name":"LAROSA JOSEPH J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP General Counsel and Secret"}}],"security":"Common Stock","published_at":"2020-04-20T23:26:56.000Z","date":"2020-04-17","kind":"tax_withholding","acquired":false,"shares":2720,"price":555.82,"value":1511830.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19738,"source":{"system":"sec-edgar","filing":"0001708138-20-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000042/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-04-20T23:26:56.000000Z,3173359"}